The CDC’s vaccine advisors on Thursday maintained that respiratory syncytial virus immunization is only recommended for ...

Sanofi and partner AstraZeneca recently increased production capacity for their RSV antibody shot, sales of which jumped ...

Experts share the official predictions for RSV surge levels in 2024 and 2025, why the levels change each year, and how to ...

Roche announces third-quarter and nine-month results. Sanofi holds exclusive talks with CD&R to sell a 50% stake in Opella.

Respiratory season is among us, and Respiratory Syncytial Virus immunizations are now available for older adults and pregnant ...

Sanofi and CD&R entered into exclusive negotiations for the potential sale and purchase of a 50% controlling stake in Opella.

Recent findings from a multi-state study reveal that the RSV vaccine is approximately 80% effective in preventing severe ...

Respiratory syncytial virus, or RSV, typically presents as mild, with symptoms similar to the common cold for adults and ...

On a Friday call with analysts, Sanofi execs pointed to an efficacy edge for its preventive and stressed that more ...

Marinus said it will discontinue development of the drug, ganaxolone, and take further steps to reduce costs, including job ...

See your plan by selecting location, age, and other applicable factors Sign up to be alerted when there are vaccination updates in your state: The Plan Your Vaccine page will be updated as new ...

With both candidates in Texas, Trump takes aim at his rival's immigration policy while Harris pledges to codify the right to abortion. Brothers Lyle and Erik Menendez are serving jail sentences ...